StockIQ.techLabcorp Holdings Inc. (LH) Stock Analysis
Free AI-powered analysis and research for Labcorp Holdings Inc. stock
Sector: Healthcare
LH snapshot
Data as of 4 Nov 2026 close. Updated daily.
Labcorp Holdings Inc. scores 83/100 on StockIQ's model, which reads as strongly positive signals overall. The price is above its 200-day average and at 96% of its 52-week range, up 44.8% over the past year. Latest reported figures show a profit margin of 6.9%, return on equity of 11.4% and revenue growth of +6.9%.
What is driving the score
- Strong Uptrend: +12
- MACD Bullish: +8
- Weak Liquidity (1.41 Current Ratio): -5
- Strong Long-term Uptrend: +8
- Strong Momentum (+44.8% over 1 year): +8
- Low Volume (0.3x): -3
- Near 52-Week High (96%): +5
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full LH report
Labcorp Holdings Inc. (LH) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze LH Now →📰 Latest Update
Labcorp’s Q3 earnings call: our top 5 analyst questions
Mon, November 2, 2026 at 9:17 PM UTC 3 min read
Labcorp reported strong Q3 results, with revenue of $3.81 billion, exceeding analyst expectations, and an adjusted EPS of $4.78. CEO Adam Schechter highlighted growth in specialty testing and biopharma services, while addressing analyst concerns about maintaining margins amid PAMA-related pressures and recent acquisitions. The company slightly raised its full-year revenue and adjusted EPS guidance, reflecting confidence in its operational strategies and integration plans for new acquisitions.